Literature DB >> 11914168

Assessment and treatment of depression in medically ill children.

Eyal Shemesh1, Abraham Bartell, Jeffrey H Newcorn.   

Abstract

The consequences of depression in medically ill children include the disability and morbidity that is associated with depression in any patient. They also include an exacerbation of the underlying medical disease and nonadherence to treatment. Thus, medically ill children who are depressed constitute a special, high-risk group of patients who may suffer from severe consequences above and beyond those that are expected in a medically sound population. This manuscript reviews methodologic and practical difficulties that are associated with the diagnosis and treatment of depression in this group of patients. Because treatment of depression in medically ill children may well lead to improvement in medical and psychiatric outcome, there is pressing need for the careful study of potential treatment options in this specific group of patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914168     DOI: 10.1007/s11920-002-0040-7

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  47 in total

1.  Non-adherence in pediatric liver transplant recipients--an assessment of risk factors and natural history.

Authors:  S Lurie; E Shemesh; P A Sheiner; S Emre; H L Tindle; L Melchionna; B L Shneider
Journal:  Pediatr Transplant       Date:  2000-08

2.  Maternal depression, assessment methods, and physical symptoms affect estimates of depressive symptomatology among children with cancer.

Authors:  R K Mulhern; D L Fairclough; B Smith; S M Douglas
Journal:  J Pediatr Psychol       Date:  1992-06

3.  Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus.

Authors:  M de Groot; A M Jacobson; J A Samson; G Welch
Journal:  J Psychosom Res       Date:  1999-05       Impact factor: 3.006

4.  Health and disability costs of depressive illness in a major U.S. corporation.

Authors:  B G Druss; R A Rosenheck; W H Sledge
Journal:  Am J Psychiatry       Date:  2000-08       Impact factor: 18.112

5.  Depression in children and adolescents with sickle-cell disease.

Authors:  Y M Yang; M Cepeda; C Price; A Shah; V Mankad
Journal:  Arch Pediatr Adolesc Med       Date:  1994-05

6.  Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up.

Authors:  J G Simeon; V F Dinicola; H B Ferguson; W Copping
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1990       Impact factor: 5.067

7.  Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.

Authors:  A Apter; G Ratzoni; R A King; A Weizman; I Iancu; M Binder; M A Riddle
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Mar-Apr       Impact factor: 8.829

8.  Dimensions of the Center of Epidemiological Studies-Depression Scale for people with arthritis from the UK.

Authors:  J H Barlow; C C Wright
Journal:  Psychol Rep       Date:  1998-12

9.  Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

Authors:  T Ibbotson; P Maguire; P Selby; T Priestman; L Wallace
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

10.  Combined medical and psychological symptoms: impact on disability and health care utilization of patients with arthritis.

Authors:  F M Vali; J Walkup
Journal:  Med Care       Date:  1998-07       Impact factor: 2.983

View more
  2 in total

1.  Children's psychological distress during pediatric HSCT: parent and child perspectives.

Authors:  Grace Chang; Sara J Ratichek; Christopher Recklitis; Karen Syrjala; Sunita K Patel; Lynnette Harris; Angie Mae Rodday; Hocine Tighiouart; Susan K Parsons
Journal:  Pediatr Blood Cancer       Date:  2011-05-25       Impact factor: 3.167

2.  Neighborhood Stress, Depressive Symptoms, and Asthma Morbidity in Youth.

Authors:  Erin T Tobin; Samuele Zilioli; Ledina Imami; Daniel J Saleh; Heidi S Kane; Richard B Slatcher
Journal:  J Pediatr Psychol       Date:  2016-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.